BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 20211017)

  • 1. The expression level of HJURP has an independent prognostic impact and predicts the sensitivity to radiotherapy in breast cancer.
    Hu Z; Huang G; Sadanandam A; Gu S; Lenburg ME; Pai M; Bayani N; Blakely EA; Gray JW; Mao JH
    Breast Cancer Res; 2010; 12(2):R18. PubMed ID: 20211017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The histone chaperone HJURP is a new independent prognostic marker for luminal A breast carcinoma.
    Montes de Oca R; Gurard-Levin ZA; Berger F; Rehman H; Martel E; Corpet A; de Koning L; Vassias I; Wilson LO; Meseure D; Reyal F; Savignoni A; Asselain B; Sastre-Garau X; Almouzni G
    Mol Oncol; 2015 Mar; 9(3):657-74. PubMed ID: 25497280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic and Therapeutic Significance of Adhesion-regulating Molecule 1 in Estrogen Receptor-positive Breast Cancer.
    Wu W; Zhong J; Chen J; Niu P; Ding Y; Han S; Xu J; Dai L
    Clin Breast Cancer; 2020 Apr; 20(2):131-144.e3. PubMed ID: 31669266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of interferon regulating factor 4 (IRF4) in node-negative breast cancer.
    Heimes AS; Madjar K; Edlund K; Battista MJ; Almstedt K; Gebhard S; Foersch S; Rahnenführer J; Brenner W; Hasenburg A; Hengstler JG; Schmidt M
    J Cancer Res Clin Oncol; 2017 Jul; 143(7):1123-1131. PubMed ID: 28251349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioinformatics analysis of prognostic value of
    Chen WX; Cheng L; Xu LY; Qian Q; Zhu YL
    Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30837324
    [No Abstract]   [Full Text] [Related]  

  • 6. DC-SCRIPT: nuclear receptor modulation and prognostic significance in primary breast cancer.
    Ansems M; Hontelez S; Looman MW; Karthaus N; Bult P; Bonenkamp JJ; Jansen JH; Sweep FC; Span PN; Adema GJ
    J Natl Cancer Inst; 2010 Jan; 102(1):54-68. PubMed ID: 20008677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ANLN is a prognostic biomarker independent of Ki-67 and essential for cell cycle progression in primary breast cancer.
    Magnusson K; Gremel G; Rydén L; Pontén V; Uhlén M; Dimberg A; Jirström K; Pontén F
    BMC Cancer; 2016 Nov; 16(1):904. PubMed ID: 27863473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased Expression of Holliday Junction-Recognizing Protein (HJURP) as an Independent Prognostic Biomarker in Advanced-Stage Serous Ovarian Carcinoma.
    Li L; Li X; Meng Q; Khan AQ; Chen X
    Med Sci Monit; 2018 May; 24():3050-3055. PubMed ID: 29743473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of microarray-based RNA expression with ELISA-based protein determination of HER2, uPA and PAI-1 in tumour tissue of patients with breast cancer and relation to outcome.
    Witzel ID; Milde-Langosch K; Wirtz RM; Roth C; Ihnen M; Mahner S; Zu Eulenburg C; Jänicke F; Müller V
    J Cancer Res Clin Oncol; 2010 Nov; 136(11):1709-18. PubMed ID: 20204407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. At last, a predictive and prognostic marker for radiotherapy?
    Coates P; Dewar J; Thompson AM
    Breast Cancer Res; 2010; 12(3):106. PubMed ID: 20497617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and splicing of the unfolded protein response gene XBP-1 are significantly associated with clinical outcome of endocrine-treated breast cancer.
    Davies MP; Barraclough DL; Stewart C; Joyce KA; Eccles RM; Barraclough R; Rudland PS; Sibson DR
    Int J Cancer; 2008 Jul; 123(1):85-8. PubMed ID: 18386815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Holliday junction recognition protein as a prognostic biomarker and therapeutic target for oral cancer.
    Tsevegjav B; Takano A; Zhu M; Yoshitake Y; Shinohara M; Daigo Y
    Int J Oncol; 2022 Mar; 60(3):. PubMed ID: 35103286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of HJURP inhibits non-small cell lung cancer cell proliferation, migration, and invasion by repressing Wnt/β-catenin signaling.
    Wei Y; Ouyang GL; Yao WX; Zhu YJ; Li X; Huang LX; Yang XW; Jiang WJ
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3847-3856. PubMed ID: 31115012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of urokinase-type plasminogen activator mRNA determines adverse prognosis in ErbB2-positive primary breast cancer.
    Urban P; Vuaroqueaux V; Labuhn M; Delorenzi M; Wirapati P; Wight E; Senn HJ; Benz C; Eppenberger U; Eppenberger-Castori S
    J Clin Oncol; 2006 Sep; 24(26):4245-53. PubMed ID: 16963728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of insulin-like growth factor-binding protein-3 messenger RNA with protein expression in primary breast cancer tissues: detection of higher levels in tumors with poor prognostic features.
    Rocha RL; Hilsenbeck SG; Jackson JG; Lee AV; Figueroa JA; Yee D
    J Natl Cancer Inst; 1996 May; 88(9):601-6. PubMed ID: 8609661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validity of the proliferation markers Ki67, TOP2A, and RacGAP1 in molecular subgroups of breast cancer.
    Milde-Langosch K; Karn T; Müller V; Witzel I; Rody A; Schmidt M; Wirtz RM
    Breast Cancer Res Treat; 2013 Jan; 137(1):57-67. PubMed ID: 23135572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Identification of the differentially expressed genes between primary breast cancer and paired lymph node metastasis through combining mRNA differential display and gene microarray].
    Feng YM; Gao G; Zhang F; Chen H; Wan YF; Li XQ
    Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(39):2749-55. PubMed ID: 17199993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic influence of cyclooxygenase-2 protein and mRNA expression in node-negative breast cancer patients.
    Sicking I; Rommens K; Battista MJ; Böhm D; Gebhard S; Lebrecht A; Cotarelo C; Hoffmann G; Hengstler JG; Schmidt M
    BMC Cancer; 2014 Dec; 14():952. PubMed ID: 25511800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Relevance of HJURP Expression in Patients with Surgically Resected Colorectal Cancer.
    Kang DH; Woo J; Kim H; Kim SY; Ji S; Jaygal G; Ahn TS; Kim HJ; Kwak HJ; Kim CJ; Baek MJ; Jeong D
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of ERBB family mRNA expression in breast carcinomas.
    Bièche I; Onody P; Tozlu S; Driouch K; Vidaud M; Lidereau R
    Int J Cancer; 2003 Sep; 106(5):758-65. PubMed ID: 12866037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.